indexado en
  • Abrir puerta J
  • Genamics JournalSeek
  • Claves Académicas
  • DiarioTOCs
  • InvestigaciónBiblia
  • Infraestructura Nacional de Conocimiento de China (CNKI)
  • cimago
  • Directorio de publicaciones periódicas de Ulrich
  • Biblioteca de revistas electrónicas
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catálogo en línea SWB
  • Biblioteca Virtual de Biología (vifabio)
  • Publón
  • miar
  • Servicios de indexación científica (SIS)
  • pub europeo
  • Google Académico
Comparte esta página
Folleto de diario
Flyer image

Abstracto

The Influence of Drug Loading on Caveolin-1 Mediated Intracellular Internalization of Doxorubicin Nanomicelles in vitro

Hayley Nehoff, Neha N. Parayath, Sebastien Taurin and Khaled Greish

Despite the considerable progress made in the field of anticancer nanomedicine, the influence of the physicochemical characteristics of the nanoconstructs on their internalization and cytotoxicity towards specific cancer cells remains to be fully understood. The aim of this in vitro study was to examine the factors influencing the potency of styrene maleic acid (SMA-Dox) micelles loaded with doxorubicin in a range of 4.4% to 28.4% using breast cancer and prostate cancer cell lines. A significant difference in cytotoxicity relative to micelle loading was observed and correlated with the expression level of caveolin-1. The expression level of caveolin-1 has previously been associated with advanced, aggressive cancer subtypes. For example, SMA-Dox micelles were shown to co-localize with caveolin-1 in PC3 cells and this colocalization was disrupted by treatment with the caveolin-1 inhibitor, genistein. The results of this study are indicative that the micelle loading and cellular expression of caveolin-1 modulates the relative cytotoxicity of nanoconstructs of different loading against breast and prostate cancer cell lines in vitro. The expression level of caveolin-1 is a factor to consider when developing nanoconstructs for the treatment of breast and prostate cancers.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado